FDA grants Shanghai-based Zhimeng Biopharma an orphan drug designation for its small-molecule KCNQ2/3 selective opener compound (CB03) for treating am...
FDA approves a Medtronic PMA for the Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan defi...
FDA grants Genentech accelerated approval for an expanded use for Rozlytrek (entrectinib) in treating pediatric patients older than one month with sol...
Fresenius Medical Care recalls some of its 2008 Series Hemodialysis Machines because patients may be exposed to toxic compounds that leach from some p...
FDA approves a new indication for Servier Pharmaceuticals Tibsovo to treat adults with some myelodysplastic syndromes as detected by an Abbott compani...
FDA posts a revised draft guidance entitled Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of ...
FDA sets the rates and payment procedures for fiscal year 2024 generic new animal drug program user fees.
Federal Register notice: FDA announces the rates and payment procedures for fiscal year 2024 animal drug user fees.